Here you will find our english reports.
-
Sweden has Europe’s most effective system for the substitution of pharmaceuticals The assignment of the Dental and Pharmaceutical Benefits Agency (TLV) includes monitoring and analysing the development of pharmaceutical prices in...30 Jan 2026
-
Needs-based dental care – A model for the future – summary In June 2024, the Dental and Pharmaceuticals Benefits Agency (TLV) was tasked by the Swedish government to support the National Board of Health and...31 Mar 2025
-
Swedish pharmaceutical prices continue to be low due to a weak krona From an international perspective, Swedish pharmaceutical prices are relatively low. The weak Swedish krona (SEK) is one significant explanation as...11 Feb 2025
-
Comparative theoretical study of pull incentives for antibiotics development A comparative analysis by TLV found that AMR-vouchers, particularly as they are proposed by the European Commission, is the least cost-effective in...26 Feb 2024
-
Swedish prices on pharmaceuticals decrease with a weakening Swedish krona Swedish pharmaceutical prices are relatively low when considered in an international perspective. In 2023, prices in Sweden were the lowest for pha...04 Jan 2024
-
Strenghened access to medicines for rare disesases - summary TLV (the Dental and Pharmaceutical Benefits Agency) has been assigned by the government to analyse and propose how to strengthen access to medicine...20 Oct 2023
-
TLV’s annual international price comparison of pharmaceuticals The price of prescription pharmaceuticals in Sweden has significantly dropped since 2014, making it one of the lowest in Europe according to the an...29 Mar 2023
-
Pricing and reimbursement of pharmaceuticals in Sweden The PPRI Pharma Profile Sweden 2023 is an overview of the Swedish system for pricing and reimbursement of pharmaceuticals. It provides an introduct...08 Feb 2023
-
Calculation and payment. Continued study on evaluation methods and payment models for new medicines, such as ATMPs, and precision medicine - 2022 In this report, the Dental and Pharmaceutical Benefits Agency (TLV) reports on the work done in the context of a government commissioned project to...27 Jan 2023
-
How should we assess and pay? Health-economic assessments and payment models for precision medicines and ATMPs – 2021 In this report, TLV describes the challenges we consider to be most critical to health economic assessments of precision medicine and ATMP, and als...18 Aug 2022
-
Improved price dynamics needed during the life cycle of a pharmaceutical product TLV’s annual international price comparison of pharmaceuticals 2021 Sweden's relative pharmaceutical prices are the sixth lowest in the segment Ph...18 Mar 2022
-
TLV’s report on developed follow-ups with data from sources such as the National Service Platform Health care providers and patients expect access to innovative new pharmaceuticals. Since subsidy applications for these pharmaceuticals often incl...08 Mar 2022
-
International price comparison 2020 When the first report was published in 2014, Swedish pharmaceutical prices were higher than the European average. Since then, Sweden’s prices have ...28 Jan 2021
-
Developed follow-ups with data from sources such as the National Service Platform The ability to follow-up on the utilisation of pharmaceuticals and treatment effects is a prerequisite for ensuring TLV is able to contribute to th...09 Dec 2020
-
TLV’s annual international price comparison of pharmaceuticals For pharmaceuticals without competition, Sweden's prices have fallen by around 17 percentage points between 2014 and 2019 compared to European coun...14 Feb 2020
-
Swedish pharmaceutical prices are decreasing as a result of a weaker krona Since 2014, Sweden has experienced lower prices in relative terms for pharmaceuticals compared to other European countries. The prices of pharmaceu...10 Apr 2019
-
TLV's annual international price comparison of pharmaceuticals Sweden, Denmark and the Netherlands have significantly lower prices on pharmaceuticals that are subject to competition (in the ‘product-of-the-mont...06 Aug 2018
-
An overview of the Swedish system for pricing and reimbursement of pharmaceuticals23 Jan 2018
-
Sweden receives SEK one billion in refunds from the pharmaceutical industry “Managed Entry Agreements provide the opportunity to cope with uncertainties when bringing new innovative and effective pharmaceuticals to patients...19 Dec 2017
-
An overview of the Swedish system for pricing and reimbursement of pharmaceuticals The Swedish system of substitutable pharmaceuticals with a 'product-of-the-month' quickly brings down the prices of prescription pharmaceuticals. T...10 Apr 2017
-
TLV's annual international price comparison of pharmaceuticals "Sweden belongs to a group of three countries, together with Denmark and the Netherlands, that has significantly lower prices for pharmaceuticals e...01 Feb 2017